Preventing Allergic Reactions to Peanuts with a Cancer Drug Clinician's Roundtable

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Melanie Dispenza, MD



The future therapeutic landscape for food allergy prevention is looking clearer as a drug typically used to treat hematologic malignancies has shown to prevent systemic anaphylaxis to allergens and increase patients' tolerance to peanuts. Along with this, other therapies are also in development for allergy treatment. To learn more, join Dr. Charles Turck as he dives deeper into this study and its findings with Dr. Melanie Dispenza, Assistant Professor of Medicine at Johns Hopkins University School of Medicine.